Skip to content
Screener

Opko Health OPK Accrued Expenses

Accrued Expenses at other companies

Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$6.01M-0.2%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$15M+481%
Exelixis logo
ExelixisEXEL
$102.66M+1.3%
PTH
Pelthos TherapeuticsPTHS
$1.93M
ALN
Alnylam PharmaceuticalsALNY
$1.1B+19.3%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$13.47B-22.5%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$1.04B+0.5%
P/S1.8×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemJune 30, 2026December 31, 2025
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable$50,043$41,103
Accrued expenses77,75784,406
Current maturities of operating leases11,00910,917
Current portion of lines of credit and notes payable10,55810,251
Total current liabilities149,367146,677
Operating lease liabilities33,98036,815

Item 1. Financial Statements

FAQ

What is Opko Health's accrued expenses?
Opko Health (OPK) reported accrued expenses of $77.76M in Q2 2026.
How has Opko Health's accrued expenses changed year-over-year?
Opko Health's accrued expenses decreased by 14.1% year-over-year, from $90.56M to $77.76M.
What is the long-term trend for Opko Health's accrued expenses?
Over 5 years (2020 to 2025), Opko Health's accrued expenses has grown at a -18.9% compound annual growth rate (CAGR), from $240.87M to $84.41M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Opko Health's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude